Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients

Tofacitinib Decreases Autophagy of Fibroblast-Like Synoviocytes From Rheumatoid Arthritis Patients

The pathway of Janus tyrosine kinases (JAKs) has a central role in the pathogenesis of Rheumatoid Arthritis (RA) by regulating multiple immune functions and cytokine production. The JAK inhibitor tofacitinib is effective in RA patients not responding to methotrexate or TNF-inhibitors. Since hyperact...

Full description

Bibliographic Details
Main Authors:	M. Vomero, M. Caliste, C. Barbati, M. Speziali, A. I. Celia, F. Ucci, C. Ciancarella, E. Putro, T. Colasanti, G. Buoncuore, E. Corsiero, M. Bombardieri, F. R. Spinelli, F. Ceccarelli, F. Conti, C. Alessandri
Format:	Article
Language:	English
Published:	Frontiers Media S.A. 2022-03-01
Series:	Frontiers in Pharmacology
Subjects:	Rheumatoid arthritis tofacitinib janus tyrosine kinases autophagy apoptosis
Online Access:	https://www.frontiersin.org/articles/10.3389/fphar.2022.852802/full

Similar Items

Profile of Tofacitinib in the Treatment of Ulcerative Colitis: An Evidence-Based Review of Recent Data
by: Varyani F, et al.
Published: (2019-12-01)

Tofacitinib May Inhibit Myofibroblast Differentiation from Rheumatoid-Fibroblast-like Synoviocytes Induced by TGF-β and IL-6
by: Piero Ruscitti, et al.
Published: (2022-05-01)

Transient Efficacy of Tofacitinib in Alopecia Areata Universalis
by: Florian Anzengruber, et al.
Published: (2016-04-01)

Glucocorticoids combined with tofacitinib for systemic sarcoidosis with rash as initial symptom: a case report
by: Hu Rongrong, Hong Yixin, Su Xiangyang, Ma Guiyan, Chen Peiran
Published: (2023-05-01)

Tofacitinib in the management of active psoriatic arthritis: patient selection and perspectives
by: Ly K, et al.
Published: (2019-08-01)

Efficacy and safety of tofacitinib therapy in Asian patients with severe alopecia areata
by: Ying-Xiu Dai, et al.
Published: (2020-01-01)

Peripheral neuropathy associated with tofacitinib use in alopecia universalis
by: Raghad Alharthi, et al.
Published: (2022-01-01)

Repigmentation of vitiligo-associated eyelash leukotrichia with topical tofacitinib
by: Sa Rang Kim, MD, et al.
Published: (2021-10-01)

Inhibition of pSTAT1 by tofacitinib accounts for the early improvement of experimental chronic synovitis
by: Sandra Pérez-Baos, et al.
Published: (2019-01-01)

Topical Tofacitinib: A Janus Kinase Inhibitor for the Treatment of Vitiligo in an Adolescent Patient
by: Sineida Berbert Ferreira, et al.
Published: (2021-04-01)

Efficacy of Tofacitinib for the Treatment of Psoriatic Arthritis: Pooled Analysis of Two Phase 3 Studies
by: Peter Nash, et al.
Published: (2018-11-01)

Tofacitinib is a modern solution to the problem of resistant rheumatoid arthritis
by: I. V. Menshikova, et al.
Published: (2019-05-01)

Integrated safety analysis of tofacitinib from Phase 2 and 3 trials of patients with ankylosing spondylitis
by: Atul Deodhar, et al.
Published: (2024-12-01)

Tofacitinib citrate for the treatment of refractory, severe chronic actinic dermatitis
by: Matthew D. Vesely, MD, PhD, et al.
Published: (2017-01-01)

Various Applications of Tofacitinib and Ruxolitinib (Janus Kinase Inhibitors) in Dermatology and Rheumatology: A Review of Current Evidence and Future Perspective
by: Sara Sadeghi, et al.
Published: (2022-10-01)

Treatment of angiolupoid sarcoidosis with tofacitinib ointment 2% and pulsed dye laser therapy
by: Katelyn Singh, BS, et al.
Published: (2021-01-01)

Two cases of bullous pemphigoid effectively treated with oral tofacitinib
by: Soundos Youssef, MD, et al.
Published: (2023-02-01)

Oral tofacitinib citrate for recalcitrant cutaneous lupus
by: Evelyne Bonnardeaux, MD, et al.
Published: (2022-02-01)

Long-Term Retention Rate of Tofacitinib in Rheumatoid Arthritis: An Italian Multicenter Retrospective Cohort Study
by: Marino Paroli, et al.
Published: (2023-08-01)

The positive effect of JAK inhibitor tofacitinib in the treatment of primary Sjögren’s syndrome: a clinical case
by: D.G. Rekalov, et al.
Published: (2023-03-01)

Fulminant Demodex folliculitis in a patient with ulcerative colitis treated with tofacitinib
by: Carolina Neudorfer, MD, et al.
Published: (2023-09-01)

Janus kinase inhibitor, tofacitinib, in refractory juvenile dermatomyositis: a retrospective multi-central study in China
by: Junmei Zhang, et al.
Published: (2023-10-01)

Treatment of cutaneous sarcoidosis with tofacitinib: A case report and review of evidence for Janus kinase inhibition in sarcoidosis
by: Ronan Talty, BS, et al.
Published: (2021-10-01)

Improvement of necrobiosis lipoidica with topical ruxolitinib cream after prior nonresponse to compounded topical tofacitinib cream
by: Shannon Nugent, BS, et al.
Published: (2022-11-01)

Synthesis and evaluation of hydrogen peroxide sensitive tofacitinib prodrugs
by: Viola Previtali, et al.
Published: (2022-04-01)

Case Report: Successful Treatment of Alopecia Universalis With Tofacitinib and Increased Cytokine Levels: Normal Therapeutic Reaction or Danger Signal?
by: Ling Yu, et al.
Published: (2022-06-01)

Tofacitinib and Baricitinib in Type 2 Diabetic Patients with Rheumatoid Arthritis
by: Cristina Martinez-Molina, et al.
Published: (2024-02-01)

Oral Tofacitinib and Systemic Corticosteroids, Alone or in Combination, in Patients With Moderate-to-Severe Alopecia Areata: A Retrospective Study
by: Wenxin Zhang, et al.
Published: (2022-06-01)

A case of aggressive squamous cell carcinoma with lymphovascular invasion during treatment with the Janus kinase inhibitor tofacitinib
by: Ahmad I. Aleisa, MD, et al.
Published: (2020-08-01)

Autophagy Modulation in Lymphocytes From COVID-19 Patients: New Therapeutic Target in SARS-COV-2 Infection
by: Marta Vomero, et al.
Published: (2020-11-01)

Real-World Experience of Tofacitinib and Baricitinib Use in Alopecia Areata in Greek Population: A Retrospective Analysis With Focus on Safety
by: Zoe Apalla, et al.
Published: (2024-04-01)

Pharmacokinetic and safety profile of tofacitinib in children with polyarticular course juvenile idiopathic arthritis: results of a phase 1, open-label, multicenter study
by: Nicolino Ruperto, et al.
Published: (2017-12-01)

Oral tofacitinib: Contemporary appraisal of its role in dermatology
by: Sidharth Sonthalia, et al.
Published: (2019-01-01)

Clinical response to adjunctive platelet-rich plasma injections in a patient with alopecia universalis on oral tofacitinib
by: Sophia A. Ederaine, BA, et al.
Published: (2022-02-01)

Tofacitinib
by: Nilgün Şentürk
Published: (2022-04-01)

Clinical response to oral tofacitinib in pediatric patients with alopecia areata
by: Soundos Youssef, MD, et al.
Published: (2023-01-01)

Efficacy and safety of tofacitinib in moderate and severe ulcerative colitis in real clinical practice: three years of observation
by: O. V. Knyazev, et al.
Published: (2021-10-01)

An Open-Label, Investigator-Initiated, Single-Centre Pilot Study to Determine the Safety and Efficacy of Tofacitinib in Resistant Chronic Spontaneous Urticaria
by: Abhishek De, et al.
Published: (2024-08-01)

Tofacitinib: Revisión
by: Carlos Ríos Acosta, et al.
Published: (2016-12-01)

First‐trimester exposure to tofacitinib in ulcerative colitis: A case report of a healthy newborn and literature review
by: Arteen Arzivian, et al.
Published: (2024-04-01)